EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Domain: All, EUROVOC descriptor: pharmaceutical product, Search language: English
2

Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems

In force

CELEX number:
32006R0816
Form:
Regulation
Author:
European Parliament, Council of the European Union
Date of document:
17/05/2006

Case T-150/22: Action brought on 21 March 2022 — Lilly Drogerie v EUIPO — Lillydoo (LILLYDOO kids)

CELEX number:
62022TN0150
Form:
Judicial information
Author:
General Court
Date of document:
21/03/2022

Case T-138/22: Action brought on 15 March 2022 — HCP v EUIPO — Timm Health Care (PYLOMED)

CELEX number:
62022TN0138
Form:
Judicial information
Author:
General Court
Date of document:
15/03/2022

Case T-315/21: Judgment of the General Court of 16 March 2022 — Laboratorios Ern v EUIPO — Nordesta (APIAL) (EU trade mark — Opposition proceedings — Application for EU word mark APIAL — Earlier EU word mark APIRETAL — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001 — No damage to reputation — Article 8(5) of Regulation 2017/1001 — Evidence submitted for the first time before the General Court)

CELEX number:
62021TA0315
Form:
Judicial information
Author:
General Court
Date of document:
16/03/2022

Case T-140/21: Judgment of the General Court of 2 March 2022 — Apologistics v EUIPO — Kerckhoff (apo-discounter.de) (EU trade mark — Revocation proceedings — EU figurative mark apo-discounter.de — Partial revocation — Genuine use of the trade mark — Article 58(1)(a) of Regulation (EU) 2017/1001 — Proof of genuine use)

CELEX number:
62021TA0140
Form:
Judicial information
Author:
General Court
Date of document:
02/03/2022

Case C-149/22: Reference for a preliminary ruling from the Supreme Court (Ireland) made on 2 March 2022 — Merck Sharp & Dohme Corp v Clonmel Healthcare Limited

CELEX number:
62022CN0149
Form:
Judicial information
Author:
Court of Justice
Date of document:
02/03/2022

Case T-715/20: Judgment of the General Court of 2 March 2022 — Degode- v EUIPO — Leo Pharma (Skinovea) (EU trade mark — Opposition proceedings — Application for the EU word mark Skinovea — Earlier national word mark SKINOREN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

CELEX number:
62020TA0715
Form:
Judicial information
Author:
General Court
Date of document:
02/03/2022

Case T-149/21: Judgment of the General Court of 2 March 2022 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark VITADHA — Earlier Spanish word mark VITANADH — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

CELEX number:
62021TA0149
Form:
Judicial information
Author:
General Court
Date of document:
02/03/2022

Commission Implementing Regulation (EU) 2022/527 of 1 April 2022 granting a Union authorisation for the single biocidal product ‘ARIEL chlorine Professional System 5 chlorine bleach for white wash’ (Text with EEA relevance)

C/2022/1929

In force

CELEX number:
32022R0527
Form:
Implementing regulation
Author:
European Commission, Directorate-General for Health and Food Safety
Date of document:
01/04/2022; Date of adoption

Case T-37/22: Action brought on 19 January 2022 — Romedor Pharma v EUIPO — Perfect Care Distribution (Cerviron)

CELEX number:
62022TN0037
Form:
Judicial information
Author:
General Court
Date of document:
19/01/2022
2